Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
Hemasphere. 2023 Aug 30;7(9):e940.
doi: 10.1097/HS9.0000000000000940.
eCollection 2023 Sep.
1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands.
2 Cancer Center Amsterdam, Treatment and Quality of Life, the Netherlands.
3 Department of Hematology, Oslo Myeloma Center, Oslo University Hospital, Norway.
4 KG Jebsen Center for B Cell Malignancies, University of Oslo, Norway.
5 Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
6 Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
7 Department of Hematology, Skåne University Hospital Lund, Sweden.
8 Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands.
9 Department of Internal Medicine, Meander Medical Centre, Amersfoort, the Netherlands.
10 Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
11 Department of Oncology and Hematology, Førde Central Hospital, Norway.
12 Department of Internal Medicine, Helsingborg Hospital, Sweden.
13 Haematology Department H 60, Roskilde Sjaelland University, Denmark.
14 Department of Hematology, Aalborg University Hospital, Denmark.
15 Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands.
16 Department for Blood and Cancer Diseases, Stavanger University Hospital, Norway.
17 Institute of Heamatology, Uddevalla Hospital, Sweden.
18 Department of Hematology, Haga Hospital, The Hague, the Netherlands.
19 Hematology Department, Sahlgrenska University Hospital, Gothenburg, Sweden.
20 Department of Internal Medicine, Sodra Alvsborgs Sjukhus, Boras, Sweden.
21 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
22 Department of Hematology, Aarhus University Hospital, Denmark.
23 Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
24 Department of Hematology, Hematology Research Unit and Academy of Geriatric Research, Odense University Hospital and University of Southern Denmark, Denmark.